1-Hydroxybenzotriazole → 2,2,3,3-Tetramethylcyclopropanecarboxylic acid (4-methyl-5-morpholin-4-yl-thiazol-2-yl)-amide

HRID 78417

반응식

HRID 78417 반응식
[CH3:1][C:2]1[N:3]=[C:4]([NH2:13])[S:5][C:6]=1[N:7]1[CH2:12][CH2:11][O:10][CH2:9][CH2:8]1.CCN=C=NCCCN(C)C.Cl.ON1C2C=CC=CC=2N=N1.[CH3:36][C:37]1([CH3:45])[C:39]([CH3:41])([CH3:40])[CH:38]1[C:42](O)=[O:43]>C(N(CC)CC)C>[CH3:1][C:2]1[N:3]=[C:4]([NH:13][C:42]([CH:38]2[C:39]([CH3:41])([CH3:40])[C:37]2([CH3:45])[CH3:36])=[O:43])[S:5][C:6]=1[N:7]1[CH2:8][CH2:9][O:10][CH2:11][CH2:12]1

참가 물질

6

반응물 4

HCID 757711-HydroxybenzotriazoleHCID 1521152,2,3,3-Tetramethylcyclopropanecarboxylic acidHCID 27239391,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 866189054-Methyl-5-morpholin-4-yl-thiazol-2-ylamine

생성물 1

HCID 866189042,2,3,3-Tetramethylcyclopropanecarboxylic acid (4-methyl-5-morpholin-4-yl-thiazol-2-yl)-amide

시약·촉매·용매 1

HCID 8471Triethylamine용매

실험 절차

A mixture of 4-methyl-5-morpholin-4-yl-thiazol-2-ylamine (prepared using the method described in Christopher et al., Bioorganic and Medicinal Chemistry Letters 2004, 14(22), 5521-5525), N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride, 1-hydroxybenzotriazole, triethylamine, and 2,2,3,3-tetramethylcyclopropanecarboxylic acid were processed using the method described in Example 58 to afford the title compound. MS (ESI) m/z 324 (M+H)+.

후처리

  1. customprepared

출처 및 근거

ORD 기록
ord-36a87c5f875f426fa49b4967c0c7dab9
출처 데이터셋
uspto-grants-2014_09
특허 번호
US08841334B2

연결된 노트

불러오는 중…